Vaccine Technologies and Global Markets
|
|
- Felicity Jordan
- 6 years ago
- Views:
Transcription
1 A BCC Research Pharmaceutical Report and Global Markets PHM014D Use this report to: Learn about the strengths and weaknesses of each category of human and veterinary vaccine to prevent or treat infectious disease, as well as new technologies to develop improved and innovative vaccines Validate marketing plans based on an analysis of the seven major categories of vaccines broken down by market share, revenues by region, and projected sales through 2015 Develop business strategies as new products, a general increase in public awareness, and more standardized immunization schedules converge to drive market growth Gain competitive insight into the burgeoning pipelines of vaccine manufacturers and suppliers, and how increasing investment in the research and development of new vaccines may affect your business. T: , F: sales@bccresearch.com
2 Global sales of human and animal vaccines reached approximately $25.2 billion in The market is expected to rise at a compound annual growth rate (CAGR) of 17.9% to reach $64.2 billion by Introduction A vaccine is a pharmaceutical preparation of biological ingredients that provides immunity to a particular disease. are essential when administered in the form of a vaccination as they stimulate the body s immune system to produce antibodies without infecting the body with the actual disease. As such, the use of vaccines to immunize the body has become significantly important in reducing preventable infectious diseases. While some vaccines are powerful enough to provide the body with lifelong immunity, other vaccines require multiple doses or periodic injections or booster shots to provide lifelong immunity. are an essential innovation that scientists have taken many approaches to develop. Different vaccines are developed based on the nature of the virulent microorganism and how it functions within the body to produce the necessary immune response. Following are the different types of vaccines, which are utilized to stimulate an immune response within the body: Attenuated (Live) Inactivated (Killed) Toxoid Subunit Conjugate Recombinant Vector DNA. BCC Research report Technologies - PHM014D provides the information about the human and animal (veterinary) vaccines. It also provides detailed market analysis of human and animal (veterinary) vaccines along with the different factors affecting this market. The report has been useful to the Clinicians, physicians, the pharmaceutical and biopharmaceutical industries, hospitals and research institutes. The information for the report has been collected through primary and secondary research methodologies by collecting the data through journals and through interviewing various analytical/chemical/pharmaceutical/biotechnical experts. SUMMARY FIGURE GLOBAL REVENUE OF HUMAN AND ANIMAL VACCINES, ($ MILLIONS) 60,000 50,000 $ Millions 40,000 30,000 20,000 10, Human Animal Source: BCC Research
3 Scope of Study The global market for human vaccines in 2008 was $18.7 billion and, with a continuing increase in the global market, reached $21.2 billion in This market is expected to rise at a compound annual growth rate (CAGR) of 19.6% to reach $58.6 billion by the end of The scope of this report is broad and includes: Descriptions of various human and veterinary vaccines that treat infectious diseases, chronic infections, cancer, autoimmune diseases, allergies, high blood pressure and addictions Analysis of global market trends, with data from 2009, estimates for, and projections of compound annual growth rates (CAGRs) through 2015 The latest vaccine research findings in prophylactic and therapeutic areas Discussion of significant vaccine-related patents in the Unites States and Europe An overview of the regulatory environment. Table of Contents Chapter One: Introduction Study Objectives Reasons for Doing This Study Intended Audience Scope of The Study Methodology Information Sources About The Author Related Bcc Research Reports BCC Online Services Disclaimer Chapter Two: Executive Summary Executive Summary Summary Table Global Revenue of Human and Animal, Through Summary Figure Global Revenue of Human and Animal, Chapter Three: Overview What Is A Vaccine? History of Table 1 History of, Types of Attenuated (Live) Applications of Attenuated (Live) Table 2 Applications of Attenuated (Live) Advantages and Disadvantages of Attenuated (Live) Table 3 Advantages and Disadvantages of Attenuated (Live) Inactivated (Killed) Applications of Inactivated (Killed) Table 4 Applications of Inactivated (Killed) Advantages and Disadvantages of Inactivated (Killed) Table 5 Advantages and Disadvantages of Inactived (Killed) Toxoid Applications of Toxoid Table 6 Applications of Toxoid Advantages and Disadvantages of Toxoid Table 7 Advantages and Disadvantages of Toxoid Subunit Applications of Subunit Table 8 Applications of Subunit Advantages and Disadvantages of Subunit Table 9 Advantages and Disadvantages of Subunit Conjugate Applications of Conjugate Table 10 Applications of Conjugate Advantages and Disadvantages of Conjugate Table 11 Advantages and Disadvantages of Conjugate Recombinant Vector Applications of Recombinant Vector Table 12 Applications of Recombinant Vector Advantages and Disadvantages of Recombinant Vector Table 13 Advantages and Disadvantages of Recombinant Vector DNA Applications of DNA Table 14 Applications of DNA Advantages and Disadvantages of DNA Table 15 Advantages and Disadvantages of DNA Infectious Diseases Preventable By Human Diseases Viral Diseases Table 16 Vaccine preventable Human Viral Diseases Bacterial Diseases Table 17 Vaccine preventable Human Bacterial Diseases Animal Diseases Table 18 Vaccine preventable Animal Diseases in Companion Animals Table 19 Vaccine preventable Animal Diseases in Livestock Animals Table 20 Livestock Animal Chapter Four: Prevalence Incidence and Immunization of Human Diseases Regional Data Table 21 Reported Incidence Data of Human Diseases, By Region, Table 22 Immunization Coverage Data of Human Diseases, By Region, (%) Global Data Table 23 Reported Cases of Human Diseases, 2007 and 2008 Table 24 Immunization Coverage of Human Diseases (%) Global Immunization Uptake Data Table 25 Uptake of New and Underused, 2008 Global Deaths Due To Vaccine preventable Diseases
4 The animal vaccines market grew from approximately $3.8 billion in 2008 to about $4.0 billion in 2009, an increase of about 5.9%. This market is expected to increase at a 5.7% compound annual growth rate (CAGR) between and 2015 to reach $5.6 billion in Table of Contents, Table 26 Global Child Deaths Due To Vaccine preventable Diseases, 2008 Chapter Five: Regulatory Aspects Table 27 Revisions To Existing, Table 28 New in The Global Market, Chapter Six: Industry Structure Who prequalified Vaccine Manufacturers/ suppliers Table 29 World Health Organization (Who) prequalified Manufacturers/Suppliers of Human, Manufacturers/Suppliers of Human Attenuated (Live) Table 30 Leading Manufacturers/Suppliers of Attenuated (Live) Inactivated (Killed) Table 31 Leading Manufacturers/Suppliers of Inactivated (Killed) Conjugate Table 32 Leading Manufacturers/suppliers of Conjugate Recombinant / Recombinant DNA (Rdna) Table 33 Leading Manufacturers/Suppliers of Recombinant/ Recombinant DNA (Rdna) Subunit Table 34 Leading Manufacturers/Suppliers of Subunit Toxoid Table 35 Leading Manufacturers/Suppliers of Toxoid Combination Table 36 Leading Manufacturers/Suppliers of Combination Market Shares of Industry Leaders of Human Attenuated (Live) Table 37 Global Market Shares of Manufacturers/ Suppliers of Attenuated (Live), 2009 (%) Figure 1 Global Market Shares of Manufacturers/ Suppliers of Attenuated (Live), 2009 (%) Inactivated (Killed) Table 38 Global Market Shares of Manufacturers/ Suppliers of Inactivated (Killed), 2009 (%) Figure 2 Global Market Shares of Manufacturers/ Suppliers of Inactivated (Killed), 2009 (%) Conjugate Table 39 Global Market Shares of Manufacturers/ Suppliers of Conjugate, 2009 (%) Figure 3 Global Market Shares of Manufacturers/ Suppliers of Conjugate, 2009 (%) Recombinant/Recombinant DNA (Rdna) Table 40 Global Market Shares of Manufacturers/ Suppliers of Recombinant/recombinant DNA (Rdna), 2009 (%) Figure 4 Global Market Shares of Manufacturers/ Suppliers of Recombinant/recombinant DNA (Rdna), 2009 (%) Subunit Table 41 Global Market Shares of Manufacturers/ Suppliers of Subunit, 2009 (%) Figure 5 Global Market Shares of Manufacturers/ Suppliers of Subunit, 2009 (%) Toxoid Table 42 Global Market Shares of Manufacturers/ Suppliers of Toxoid, 2009 (%) Figure 6 Global Market Shares of Manufacturers/ Suppliers of Toxoid, 2009 (%) Combination Table 43 Global Market Shares of Manufacturers/ Suppliers of Combination, 2009 (%) Figure 7 Global Market Shares of Manufacturers/ Suppliers of Combination, 2009 (%) Chapter Seven: New Developments New Developments Table 44 New Developments in The Research Pipeline of Human (As of August ) Chapter Eight: Market Analysis: Human Table 45 Global Market for Human By Region, Through Figure 8 Global Market for Human By Region, Attenuated (Live) Table 46 Global Market for Attenuated (Live), By Region, Through Figure 9 Global Market for Attenuated (Live), By Region, Inactivated (Killed) Table 47 Global Market for Inactivated (Killed), Through Figure 10 Global Market for Inactivated (Killed), Conjugate Table 48 Global Market for Conjugate, Through Figure 11 Global Market for Conjugate, Recombinant/Recombinant DNA (Rdna) Table 49 Global Market for Recombinant/ Recombinant DNA (Rdna), Through 2015 Figure 12 Global Market for Recombinant/ Recombinant DNA (Rdna), Subunit Table 50 Global Market for Subunit, Through Figure 13 Global Market for Subunit, Toxoid Table 51 Global Market for Toxoid, Through Figure 14 Global Market for Toxoid, Combination Table 52 Global Market for Combination, By Region Through Figure 15 Global Market for Combination, By Region, Market Shares of Human, By Region Table 53 Global Human Market Shares By Region, 2009 (%) Figure 16 Global Human Market Shares By Region, 2009 (%) Market Shares of Human, By Type
5 Table of Contents, continued Table 54 Global Human Market Shares By Vaccine Type, 2009 (%) Figure 17 Global Human Market Shares By Vaccine Type, 2009 (%) Chapter Nine: Animal Health Market Industry Manufacturers of Animal Health Products Table 55 Global Animal Health Revenues By Market Leaders, Table 56 Global Animal Health Market Shares By Revenue, 2009 (%) Figure 18 Global Animal Health Market Shares By Revenue, 2009 (%) Animal Table 57 Global Market for Animal, Through Figure 19 Global Market for Animal, Chapter Ten: Market By Applications Humans Table 58 Diseases and Infections With Developed Human Based On Microorganism Table 59 Diseases and Infections With Developed Human Based On Treatment Meningococcal/Pneumococcal Diseases Table 60 Global Sales of Human in Meningococcal/ Pneumococcal Diseases Market, Through Figure 20 Global Sales of Human in Meningococcal/ Pneumococcal Diseases Market, Table 61 Top selling Groups of Meningococcal/ Penumococcal for 2009 By Market Share (%) Influenza (Seasonal and Pandemic) Diseases Table 62 Global Sales of Human in Influenza Diseases Market, Through Figure 21 Global Sales of Human in Influenza Diseases Market, Table 63 Top selling Groups of Influenza By Market Share, 2009 (%) Pediatric/Polio/Pertussis/Hib Diseases Table 64 Global Sales of Human in Pediatric/ Polio Pertussis/Hib Diseases Market, Through 2015 Figure 22 Global Sales of Human in Pediatric/ Polio/Pertussis/Hib Diseases Market, Table 65 Top selling Groups of Pediatric/Polio/ pertussis/hib By Market Share, 2009 (%) Adult/Adolescent Booster Related Diseases Table 66 Global Sales of Human in Adult/Adolescent Booster related Diseases Market, Through Figure 23 Global Sales of Human in Adult/ Adolescent Booster related Diseases Market, Table 67 Top selling Groups of Adult/Adolescent Booster related By Market Share, 2009 (%) Travel and Other Endemic Diseases Table 68 Global Sales of Human in Travel and Other Endemic Diseases Market, Through 2015 Figure 24 Global Sales of Human in Travel and Other Endemic Diseases Market, Table 69 Top selling Groups of Travel and Other Endemic By Market Share, 2009 (%) HPV Disease Table 70 Global Sales of Human in Hpv Disease Market, Through Figure 25 Global Sales of Human in Hpv Disease Market, Table 71 Top selling Hpv in The Order of Their Sales, 2009 (%) Rotavirus Disease Table 72 Global Sales of Human in Rotavirus Disease Market, Through Figure 26 Global Sales of Human in Rotavirus Disease Market, Table 73 Top selling Rotavirus By Market Share, 2009 (%) Other Diseases Table 74 Global Sales of Human in Other Diseases Market, Through Figure 27 Global Sales of Human in Other Diseases Market, Table 75 Top selling Other for 2009 By Market Share (%) Market Share of Applications Table 76 Share of Various Categories of in The Human Market, 2009 (%) Figure 28 Share of Various Categories of in The Human Market, 2009 (%) Chapter Eleven: Patent Analysis Total Number of Patents Table 77 Number of Significant Patents, 2006 To Figure 29 Number of Significant Patents, 2006 To Figure 30 Percent of Significant Patents, 2006 To (%) Patents By Type and Year Table 78 Patents By Technology, 2006 To September Figure 31 Patents By Technology, 2006 To September Patents By Company Inactivated (Killed) Vaccine Technology Table 79 Number of U.S. Patents By Company Utilizing Inactivated (Killed) Vaccine Technology, 2006 To Spetember Figure 32 Number of U.S. Patents By Company Utilizing Inactivated (Killed) Vaccine Technology, 2006 To Attenuated (Live) Vaccine Technology Table 80 Number of U.S. Patents By Company Utilizing Attenuated (Live) Vaccine Technology, 2006 To Figure 33 Number of U.S. Patents By Company Utilizing Attenuated (Live) Vaccine Technology, 2006 To Conjugate Vaccine Technology Table 81 Number of U.S. Patents By Company Utilizing Conjugate Vaccine Technology, 2006 To Figure 34 Number of U.S. Patents By Company Utilizing Conjugate Vaccine Technology, 2006 To Toxoid Vaccine Technology Table 82 Number of U.S. Patents By Company Utilizing Toxoid Vaccine Technology, 2006 To
6 Table of Contents, continued Figure 35 Number of U.S. Patents By Company Utilizing Toxoid Vaccine Technology, 2006 To Recombinant/Rdna Vaccine Technology Table 83 Number of U.S. Patents By Company Utilizing Recombinant/rdna Vaccine Technology, 2006 To Figure 36 Number of U.S. Patents By Company Utilizing Recombinant/rdna Vaccine Technology, 2006 To Subunit Vaccine Technology Table 84 Number of U.S. Patents By Company Utilizing Subunit Vaccine Technology, 2006 To Figure 37 Number of U.S. Patents By Company Utilizing Subunit Vaccine Technology, 2006 To Other/Combined Vaccine Technology Table 85 Number of U.S. Patents By Company Utilizing Other/Combined Vaccine Technology, 2006 To Figure 38 Number of U.S. Patents By Company Utilizing Other/ Combined Vaccine Technology, 2006 To Patents By Country Inactivated (Killed) Vaccine Technology Table 86 Number of U.S. Patents By Country Utilizing Inactivated (Killed) Vaccine Technology, 2006 To Figure 39 Number of U.S. Patents By Country Utilizing Inactivated (Killed) Vaccine Technology, 2006 To Attenuated (Live) Vaccine Technology Table 87 Number of U.S. Patents By Country Utilizing Attenuated (Live) Vaccine Technology, 2006 To Figure 40 Number of U.S. Patents By Country Utilizing Attenuated (Live) Vaccine Technology, 2006 Conjugate Vaccine Technology Table 88 Number of U.S. Patents By Country Utilizing Conjugate Vaccine Technology, 2006 To September Figure 41 Number of U.S. Patents By Country Utilizing Conjugate Vaccine Technology, 2006 To September Table 89 Number of U.S. Patents By Country Utilizing Toxoid Vaccine Technology, 2006 To Figure 42 Number of U.S. Patents By Country Utilizing Toxoid Vaccine Technology, 2006 To Recombinant/ DNA/ Rdna Vaccine Technology Table 90 Number of U.S. Patents By Country Utilizing Recombinant/Dna/Rdna Vaccine Technology, 2006 To Figure 43 Number of U.S. Patents By Country Utilizing Recombinant/Dna/Rdna Vaccine Technology, 2006 To Subunit Vaccine Technology Table 91 Number of U.S. Patents By Country Utilizing Subunit Vaccine Technology, 2006 To September Figure 44 Number of U.S. Patents By Country Utilizing Subunit Vaccine Technology, 2006 To September Other/Combined Vaccine Technology Table 92 Number of U.S. Patents By Country Utilizing Other/Combined Vaccine Technology, 2006 To Figure 45 Number of U.S. Patents By Country Utilizing Other/Combined Vaccine Technology, 2006 To Table 93 Number of U.S. Patents By Country for All Vaccine Types, 2006 To (%) Figure 46 Patent Shares By Country for, 2006 To (%) Patents By Assignee Inactivated (Killed) Vaccine Technology Table 94 Patents By Assignee Utilizing Inactivated (Killed) Vaccine Technology, 2006 To Figure 47 Patents By Assignee Utilizing Inactivated (Killed) Vaccine Technology, 2006 To Attenuated (Live) Vaccine Technology Table 95 Patents By Assignee Utilizing Attenuated (Live) Vaccine Technology, 2006 Through September Figure 48 Patents By Assignee Utilizing Attenuated (Live) Vaccine Technology, 2006 To Conjugate Vaccine Technology Table 96 Patents By Assignee Utilizing Conjugate Vaccine Technology, 2006 To Figure 49 Patents By Assignee Utilizing Conjugate Vaccine Technology, 2006 To Toxoid Vaccine Technology Table 97 Patents By Assignee Utilizing Toxoid Vaccine Technology, 2006 To Figure 50 Patents By Assignee Utilizing Toxoid Vaccine Technology, 2006 To Recombinant/Rdna Vaccine Technology Table 98 Patents By Assignee Utilizing Recombinant/ rdna Vaccine Technology, 2006 To Figure 51 Patents By Assignee Utilizing Recombinant/ rdna Vaccine Technology, 2006 To Subunit Vaccine Technology Table 99 Patents By Assignee Utilizing Subunit Vaccine Technology, 2006 To Figure 52 Patents By Assignee Utilizing Subunit Vaccine Technology, 2006 To Other/Combined Vaccine Technology Table 100 Patents By Assignee Utilizing Other/ Combined Vaccine Technology, 2006 To September Figure 53 Patents By Assignee Utilizing Other/ Combined Vaccine Technology, 2006 To September Chapter Twelve: Current Situation of The Global Market Facts About The Global Market Factors Affecting The Sales of Competition Cost Trends Immunization Funding Global Immunization Vision and Strategy (Givs) Table 101 Aims of Givs Table 102 Goals of Givs Table 103 Strategies of Givs Current Situation Table 104 Global Funding Gap By Region for Immunization Work, Vaccine Preventable Diseases Update Current Vaccine Prioritization Table 105 Vaccine Prioritization, Current and Future (Proposed) Vaccine Milestones Table 106 Vaccine Milestones Influenza Virus Update for The Through 2011 Season Table 107 Influenza for The 2011 Season Chapter Thirteen: Company Profiles Advaxis Bayer Animal Health Bul Bio National Center of Infectious and Parasitic Diseases Ltd. (Bb ncipd Ltd.)
7 Table of Contents, continued Bharat Biotech Bio Farma Biological E. Limited Bio manguinhos Bioproperties Boehringer Ingelheim Vetmedica, Inc. Center for Genetic Engineering and Biotechnology Ceva Sante Animale Colorado Serum Company Crucell CSL Ltd. Eli Lilly & Co. Emergent Biosolutions Fatro Glaxosmithkline Green Cross Haffkine Bio pharmaceutical Corporation Ltd. Indovax Institut Pasteur De Dakar Intercell Japan Bcg Laboratory King Pharmaceuticals Inc. Lohmann International Medimmune Merck & Co., Inc. Nippon Biologicals, Inc. Novartis Ag Panacea Biotec Pfizer Inc. Romvac Sanofi aventis (Sanofi Pasteur) Serum Institute of India Ltd. Statens Serum Institut The Research Foundation for Microbial Diseases of Osaka University Ventri Biologicals Zydus Cadila Appendix I Abbreviations 199 pages 107 tables Related Reports DNA : Technologies ID: BIO067A Published: 09/09 ID: PHM014C Published: 01/08 Therapeutic : The Global Market ID: BIO052B Published: 03/10 About BCC Research BCC Research is a leading publisher of high-quality, technology market research reports and technical publications. BCC Research reports provide quantified measurements of the market and all major industry segments, as well as in-depth analysis of key market drivers and trends. BCC Subscriptions Access hundreds of published reports and automatically receive newly published research with a BCC Report Subscription. We can tailor a complete package of material that meets your needs and budget. BCC Custom Research Improve your strategic planning efforts with a BCC custom research study. We will work with you to determine what information is needed and deliver specific qualitative and quantitative analysis that supports your business objectives. Call or (intl), or sales@bccresearch.com for more information about any of BCC Research s products and services.
TABLE 7 ADVANTAGES AND DISADVANTAGES OF TOXOID VACCINES SUBUNIT VACCINES Applications of Subunit Vaccines TABLE 8 APPLICATIONS OF
CHAPTER ONE: INTRODUCTION... 1 STUDY OBJECTIVES... 1 REASONS FOR DOING THIS STUDY... 1 INTENDED AUDIENCE... 2 SCOPE OF THE STUDY... 2 METHODOLOGY... 2 INFORMATION SOURCES... 2 ABOUT THE AUTHOR... 3 RELATED
More informationCHAPTER ONE: EXECUTIVE SUMMARY. The Global Vaccine Industry CHAPTER TWO: INTRODUCTION TO VACCINES
CHAPTER ONE: EXECUTIVE SUMMARY The Global Vaccine Industry o Scope and Methodology o Overview o Pediatric Preventative Vaccines o The Market o Adult Preventative Vaccines o The Market o Total Market o
More informationTable Of Contents Executive Summary Introduction to Vaccines Pediatric Preventive Vaccines
Table Of Contents Executive Summary THE GLOBAL VACCINES INDUSTRY Scope and Methodology Overview Pediatric Preventative Vaccines THE MARKET Adult Preventative Vaccines THE MARKET TOTAL MARKET ISSUES AND
More informationGlobal Coverage. Regional Coverage. Company Coverage. Country Coverage. Global Coverage Regional Coverage Country Coverage
Global Influenza Drugs and Vaccines Market By Drugs (Zanamivir, Oseltamivir Phosphate, Peramivir), By Vaccine (Trivalent, Quadrivalent): Analysis By Region, By Country: Opportunities and Forecast (2016-2021)
More informationBRIC DIABETES DRUGS MARKET
BRIC DIABETES DRUGS MARKET R e p o r t D e s c r i p t i o n T a b l e o f C o n t e n t s L i s t o f T a b l e s S a m p l e T a b l e s R e l a t e d R e p o r t s A b o u t M a r k e t s a n d M a
More informationHow and Why Vaccines Are Developed by Industry. Stanley A. Plotkin
How and Why Vaccines Are Developed by Industry Stanley A. Plotkin Merieux 2012 1 Why Vaccines are Different than Drugs 1) Given to healthy people, high safety required 2) Larger governmental role 3) Low
More informationREFERENCE CODE GDHC1032FPR PUBLICAT ION DATE M ARCH 2014 PROPHYLACTIC HUMAN PAPILLOMAVIRUS VACCINES - CURRENT AND FUTURE PLAYERS
REFERENCE CODE GDHC1032FPR PUBLICAT ION DATE M ARCH 2014 PROPHYLACTIC HUMAN PAPILLOMAVIRUS VACCINES - Executive Summary Human PapillomaVirus (HPV) Vaccine Sales Expected to Grow Modestly During the Forecast
More informationContraceptives: Technologies and Global Markets
A BCC Research Healthcare Report HLC085A Use this report to: Learn how shifting demographic and sociological factors such as population growth, proportion of young population, and perceptions about family
More informationDNA VACCINES: TECHNOLOGIES AND GLOBAL MARKETS
DNA VACCINES: TECHNOLOGIES AND GLOBAL MARKETS BIO067B July 2014 Jon Evans Project Analyst ISBN: 1-56965-883-8 BCC Research 49 Walnut Park, Building 2 Wellesley, MA 02481 USA 866-285-7215 (toll-free within
More informationREFERENCE CODE GDHC386DFR PUBLICAT ION DATE M ARCH 2014 GARDASIL (PROPHYLACTIC HUMAN PAPILLOMAVIRUS VACCINES) - FORECAST AND MARKET ANALYSIS TO 2022
REFERENCE CODE GDHC386DFR PUBLICAT ION DATE M ARCH 2014 GARDASIL (PROPHYLACTIC HUMAN PAPILLOMAVIRUS VACCINES) - FORECAST AND MARKET ANALYSIS TO 2022 Executive Summary Gardasil: Key Metrics in Nine Major
More informationREGULATORY UPDATES: APPROVAL, DENIALS AND AGREEMENTS REGULATORY UPDATES: APPROVAL, (CONTINUED)... 38
CHAPTER ONE: INTRODUCTION... 1 STUDY OBJECTIVES... 1 REASONS FOR DOING THIS STUDY... 1 INTENDED AUDIENCE... 2 SCOPE OF THE STUDY... 2 METHODOLOGY... 2 INFORMATION SOURCES... 2 ABOUT THE AUTHOR... 3 RELATED
More informationGlobal HPV Vaccine Market: Analysis By End-User (Male, Female), By Age Group (Adolescents, Adults) - By Region, By Country ( )
Global HPV Vaccine Market: Analysis By End-User (Male, Female), By Age Group (Adolescents, Adults) - By Region, By Country (2017-2022) By Region- North America, Europe, APAC and RoW By Country - United
More informationTHYROID HORMONE THERAPY TABLE 21 SHARES OF MANUFACTURERS/DISTRIBUTORS FOR FIGURE 4 SHARES OF MANUFACTURERS/DISTRIBUTORS FOR
CHAPTER ONE: INTRODUCTION... 1 STUDY GOALS AND OBJECTIVES... 1 REASONS FOR DOING THIS STUDY... 1 INTENDED AUDIENCE... 1 SCOPE OF REPORT... 2 METHODOLOGY... 2 INFORMATION SOURCES... 2 ANALYST S CREDENTIALS...
More informationIntercell and Novartis form world leading strategic partnership to drive vaccines innovation
Intercell and Novartis form world leading strategic partnership to drive vaccines innovation Alliance creates opportunity for two strong innovators to combine development efforts in attractive areas Intercell
More informationInfluenza Vaccination Market Research Report Global Forecast till 2023
Report Information More information from: https://www.marketresearchfuture.com/reports/1621 Influenza Vaccination Market Research Report Global Forecast till 2023 Report / Search Code: MRFR/HC/1090-HCRR
More informationGLOBAL MARKETS FOR TREATMENT AND DIAGNOSIS OF SEXUALLY TRANSMITTED DISEASES
GLOBAL MARKETS FOR TREATMENT AND DIAGNOSIS OF SEXUALLY TRANSMITTED DISEASES PHM005C January 2013 Peggy Lehr Project Analyst ISBN: 0-89336-646-3 BCC Research 49 Walnut Park, Building 2 Wellesley, MA 02481
More informationCANCER VACCINES: TECHNOLOGIES AND GLOBAL MARKETS
CANCER VACCINES: TECHNOLOGIES AND GLOBAL MARKETS PHM173A January 2015 Shalini Shahani Dewan Project Analyst ISBN: 1-62296-008-4 BCC Research 49 Walnut Park, Building 2 Wellesley, MA 02481 USA 866-285-7215
More informationJAK AND PI3K SIGNALING PATHWAY MARKETS
JAK AND PI3K SIGNALING PATHWAY MARKETS PHM168A April 2014 Shalini Shahani Dewan Project Analyst ISBN: 1-56965-793-9 BCC Research 49 Walnut Park, Building 2 Wellesley, MA 02481 USA 866-285-7215 (toll-free
More informationREFERENCE CODE GDHC1155DFR PUBLICAT ION DATE SEPTEMBER 2013 NIMENRIX (MENINGOCOCCAL VACCINES) FORECAST AND MARKET ANALYSIS TO 2022
REFERENCE CODE GDHC1155DFR PUBLICAT ION DATE SEPTEMBER 2013 NIMENRIX (MENINGOCOCCAL VACCINES) Executive Summary Nimenrix: Key Metrics in the Nine Major Pharmaceutical Markets 2012 Market Sales US 5EU Japan
More informationREFERENCE CODE GDHC334DFR PUBLICAT ION DATE J ANU ARY 2014 ENGERIX-B (PROPHYLACTIC HEPATITIS B VIRUS VACCINES) - FORECAST AND MARKET ANALYSIS TO 2022
REFERENCE CODE GDHC334DFR PUBLICAT ION DATE J ANU ARY 2014 ENGERIX-B (PROPHYLACTIC HEPATITIS B VIRUS VACCINES) - FORECAST AND MARKET ANALYSIS TO 2022 Executive Summary The table below provides a summary
More informationVascular Endothelial Growth Factor Inhibitor Market
May 2017 Report Id : REP-GB-3292 Status : Ongoing Category : Healthcare, Pharmaceuticals & Medical Devices 2015 Future Market Insights, All Rights Reserved About Future Market Insights Future Market Insights
More informationPractical Applications of Immunology. Chapter 18
Practical Applications of Immunology Chapter 18 I. Vaccines A. Definition A suspension of organisms or fractions of organisms that is used to induce immunity (immunologic memory). The mechanism of memory
More informationREFERENCE CODE GDHC1013FPR PUBLICAT ION DATE AUGUST 2013 MENINGOCOCCAL VACCINES - CURRENT AND FUTURE PLAYERS
REFERENCE CODE GDHC1013FPR PUBLICAT ION DATE AUGUST 2013 MENINGOCOCCAL VACCINES - Executive Summary Meningococcal Vaccines: Key Metrics in the Nine Major Pharmaceutical Markets 2012 Epidemiology Targeted
More informationREFERENCE CODE GDHC1161DFR PUBLICAT ION DATE SEPTEMBER 2013 MENOMUNE (MENINGOCOCCAL VACCINES) - FORECAST AND MARKET ANALYSIS TO 2022
REFERENCE CODE GDHC1161DFR PUBLICAT ION DATE SEPTEMBER 2013 MENOMUNE (MENINGOCOCCAL VACCINES) - Executive Summary Menomune: Key Metrics in the Nine Major Pharmaceutical Markets 2012 Market Sales US 5EU
More informationGlobal Psoriasis Pipeline Drugs Market Assessment: Industry Analysis, Pipeline Review, Clinical Trials, Market Potential Forecast to 2023
Global Psoriasis Pipeline Drugs Market Assessment: Industry Analysis, Pipeline Review, Clinical Trials, Market Potential Forecast to 2023 Global Psoriasis Pipeline Drugs Industry Sizing, Growth and Forecast
More informationMEDICINES FOR SMOKING CESSATION: GLOBAL MARKETS. PHM154A September Anand Gijare Project Analyst ISBN:
MEDICINES FOR SMOKING CESSATION: GLOBAL MARKETS PHM154A September 2013 Anand Gijare Project Analyst ISBN: 1-56965-544-8 BCC Research 49 Walnut Park, Building 2 Wellesley, MA 02481 866-285-7215, 781-489-7301
More informationGlobal Influenza Vaccine Market: Industry Analysis & Outlook
Industry Research by Koncept Analytics Global Influenza Vaccine Market: Industry Analysis & Outlook ----------------------------------------- January 2017 1 Executive Summary Influenza, also known as flu,
More informationVaccines: Poised To Deliver Significant Growth in Emerging Markets
Vaccines: Poised To Deliver Significant Growth in Emerging Markets 4 th DVFA Symposium Life Science Pierre Morgon Vice-President, Franchise & Global Marketing Operations, Sanofi Pasteur Frankfurt, May
More informationCytomegalovirus (CMV) Infections - Pipeline Assessment and Market Forecasts to 2019
Reference Code: GDHC504PRT Publication Date: January 2013 Cytomegalovirus Infections: Key Metrics in Seven Major Pharmaceutical Markets 2012 Epidemiology* Prevalent population (CMV prevalent cases in general
More informationSegment Coverage By Type By Age Group. Global Coverage Regional Coverage Country Coverage
Global Cervical Cancer Diagnostics Market By Type (Pap Testing, HPV Testing, Colposcopy and Cervical Biopsies), By Age Group (35 years): Forecast to 2022 By Type - Pap Test, HPV Test,
More informationCHAPTER FOUR: UPDATE ON THE AIDS PANDEMIC TABLE 2 MILESTONES IN THE HISTORY OF HIV/AIDS TABLE 2 (CONTINUED) REGIONAL OVERVIEW...
CHAPTER ONE: INTRODUCTION... 1 STUDY GOALS AND OBJECTIVES... 1 REASONS FOR DOING THE STUDY... 1 SCOPE OF REPORT... 1 MARKET ANALYSES AND FORECASTS... 2 INTENDED AUDIENCE... 2 INFORMATION SOURCES... 2 ANALYST
More informationNew study: Tuberculosis vaccine treatment market research forecast to 20...
1 of 9 10-Dec-2016 3:11 PM Home Technology Company Directory Share your news Membership Market Research Advertise About Login Medical Health & Life Science Research News New study: Tuberculosis vaccine
More informationBiotechnology-Based Vaccines. Dr. Aws Alshamsan Department of Pharmaceutics Office: AA87 Tel:
Biotechnology-Based Vaccines Dr. Aws Alshamsan Department of Pharmaceutics Office: AA87 Tel: 4677363 aalshamsan@ksu.edu.sa Objectives of this lecture By the end of this lecture you will be able to: 1.
More informationANTITHROMBOTIC/ANTICOAGULANT DRUGS: TECHNOLOGIES AND GLOBAL MARKETS
ANTITHROMBOTIC/ANTICOAGULANT DRUGS: TECHNOLOGIES AND GLOBAL MARKETS PHM119B September 2016 Anuj Pathak Project Analyst ISBN: 1-62296-345-8 BCC Research 49 Walnut Park, Building 2 Wellesley, MA 02481 USA
More informationREFERENCE CODE GDHC68PIDR PUBLICATION DATE JANUARY 2014 PROPHYLACTIC HEPATITIS B VIRUS VACCINES - GLOBAL DRUG FORECAST AND MARKET ANALYSIS TO 2022
REFERENCE CODE GDHC68PIDR PUBLICATION DATE JANUARY 2014 PROPHYLACTIC HEPATITIS B VIRUS VACCINES - GLOBAL DRUG FORECAST AND MARKET ANALYSIS TO 2022 Executive Summary Prophylactic HBV Vaccines: Key Metrics
More informationManaging cost considerations and access to technology for cost effective vaccine manufacture in developing countries.
Managing cost considerations and access to technology for cost effective vaccine manufacture in developing countries. Amol R. Dindokar Serum Institute of India ltd. Overview Disease Control Priorities
More informationGlobal Hearing Aid Battery Market: Analysis By Battery Type, By Region, By Country: Trends, Opportunities, Restraints (2018 Edition) Forecast to 2022
Global Hearing Aid Battery Market: Analysis By Battery Type, By Region, By Country: Trends, Opportunities, Restraints (2018 Edition) Forecast to 2022 By Value (In Million USD) By Volume (In Million Units)
More informationU.S. Insomnia Market by Non-Pharmacological Therapy (CBTI, Hypnotherapy), Prescription Sleep Aids (Benzodiazepines, Non-Benzodiazepines (Zaleplon),
U.S. Insomnia Market by Non-Pharmacological Therapy (CBTI, Hypnotherapy), Prescription Sleep Aids (Benzodiazepines, Non-Benzodiazepines (Zaleplon), Orexin Antagonist) & OTC Treatment (Antihistamine, Melatonin,
More informationGlobal Health Policy: Vaccines
Global Health Policy: Vaccines Edwin J. Asturias Senior Investigator Colorado School of Public Health Department of Pediatrics Children s Hospital Colorado UNIVERSITY OF COLORADO COLORADO STATE UNIVERSITY
More informationCOPD and Asthma Devices Market by Inhalers Type (Drug powder, Metered Dose, Soft Mist), Nebulizers (Compressor, Ultrasonic, Mesh) - Global
COPD and Asthma Devices Market by Inhalers Type (Drug powder, Metered Dose, Soft Mist), Nebulizers (Compressor, Ultrasonic, Mesh) - Global Opportunity Analysis and Industry Forecasts, 2015-2022 COPD and
More informationCHAPTER ONE: EXECUTIVE SUMMARY
CHAPTER ONE: EXECUTIVE SUMMARY Introduction Scope and Methodology Total Size and Growth of the Market Issues and Trends Affecting Market Leading Competitors CHAPTER TWO: INTRODUCTION AND INDUSTRY TRENDS
More informationChina Human Vaccine Industry Report, Jun. 2016
China Human Vaccine Industry Report, 2016-2020 Jun. 2016 STUDY GOAL AND OBJECTIVES This report provides the industry executives with strategically significant competitor information, analysis, insight
More informationVaccines and other immunological antimicrobial therapy 1
Vaccines and other immunological antimicrobial therapy 1 Vaccines Vaccine: a biological preparation that provides active acquired immunity to a particular disease. Vaccine typically contains an agent that
More informationREFERENCE CODE GDHC319DFR PUBLICAT ION DATE DECEMBER 2013 EYLEA (MICROVASCULAR COMPLICATIONS OF DIABETES) - FORECAST AND MARKET ANALYSIS TO 2022
REFERENCE CODE GDHC319DFR PUBLICAT ION DATE DECEMBER 2013 EYLEA Executive Summary The table below presents a summary of the key metrics for Eylea (Microvascular Complications for Diabetes) for recombinant
More informationDIABETES CARE DEVICES MARKET IN BRAZIL, RUSSIA, INDIA & CHINA (BRIC)
DIABETES CARE DEVICES MARKET IN BRAZIL, RUSSIA, INDIA & CHINA (BRIC) R e p o r t D e s c r i p t i o n T a b l e o f C o n t e n t s L i s t o f T a b l e s S a m p l e T a b l e s R e l a t e d R e p
More informationGlobal Invisible Braces Market: Trends, Opportunities and Forecasts ( )
Global Invisible Braces Market: Trends, Opportunities and Forecasts (2016-2021) By Types Clear Aligners, Ceramic, Lingual By Region Americas, Europe, Middle East, Africa, Asia-Pacific By Country- USA,
More informationSickle-cell Anemia Therapeutics Market in the US
Sickle-cell Anemia Therapeutics Market in the US 2015-2019 Sickle-cell Anemia Therapeutics Market in the US 2015-2019 Sector Publishing Intelligence Limited (SPi) has been marketing business and market
More informationAsia-Pacific Bariatric Surgery Devices Market Outlook to 2020
Asia-Pacific Bariatric Surgery Devices Market Outlook to 2020 Reference Code: GDMECR0195DB Publication Date: July 2014 Page 1 1 Table of Contents 1 Table of Contents... 2 1.1 List of Tables... 4 1.2 List
More informationBRIC Transurethral Resection of the Prostate (TURP) Procedures Outlook to 2020
BRIC Transurethral Resection of the Prostate (TURP) Procedures Outlook Reference Code: GDMECR0130PDB Publication Date: July 2014 Page 1 1 Table of Contents 1 Table of Contents... 2 1.1 List of Tables...
More informationECONOMICS OF THE VACCINE MARKET: SIZE, GROWTH AND REVENUES
ECONOMICS OF THE VACCINE MARKET: SIZE, GROWTH AND REVENUES 1 Relationship between research funding and burden of disease Source: Global Forum for Health Research Monitoring Financial Flows for Health Research
More informationTransforming The Approach to Vaccines and Protein- Based Therapeutics. Alain Doucet, Ph.D. Manager, Process Development, Medicago
Transforming The Approach to Vaccines and Protein- Based Therapeutics Alain Doucet, Ph.D. Manager, Process Development, Medicago 2018-08-15 1 Medicago Overview 2 Novel Technologies 3 Robust Pipeline 2
More informationGlobal Prefilled Syringes Market: Trends, Opportunities and Forecasts ( )
Global Prefilled Syringes Market: Trends, Opportunities and Forecasts (2016-2021) By Material - Glass and Plastic By Filling Capabilities Single Chamber and Dual/Multiple Chamber By Major Applications
More informationChina Human Vaccine Industry Report, May 2012
China Human Vaccine Industry Report, 2011-2012 May 2012 STUDY GOAL AND OBJECTIVES This report provides the industry executives with strategically significant competitor information, analysis, insight and
More informationGlobal Transcatheter Mitral Valve Repair and Replacement (TMVR) Market: Analysis By Region, By Country: Opportunities and Forecast ( )
Global Transcatheter Mitral Valve Repair and Replacement (TMVR) Market: Analysis By Region, By Country: Opportunities and Forecast (2017-2022) By Region- North America, Europe, APAC and RoW By Country
More informationGlobal Coverage. Regional Coverage. Country Coverage Company Coverage
Global Fatty Liver Disease Drugs Market By Type (ALD, NAFLD), By Stages of ALD and NAFLD, By Region, By Country: Opportunities and Forecast (2017-2022) By Type- ALD and NAFLD ALD Stages - Alcoholic Steatosis
More informationType 1 Diabetes (T1D) Market Share, Size, Analysis, Growth, Trends and Forecasts to 2024 Hexa Research
Type 1 Diabetes (T1D) Market Share, Size, Analysis, Growth, Trends and Forecasts to 2024 Hexa Research "Type 1 diabetes market size was valued at USD 25.52 billion in 2016 and is expected to exhibit rewarding
More informationThe protective power of vaccination
The protective power of vaccination Life is a health journey which can be protected against lifethreatening infectious diseases. Smallpox used to kill millions of people worldwide 1. Polio paralyzed and
More informationGRNVAC DCVax-Brain AGS Glionix CYT004-MelQbG CDX-110 (PF ) GI TABLE 23 OCCURRENCE OF
CHAPTER ONE: INTRODUCTION.1 STUDY GOALS AND OBJECTIVES... 1 REASONS FOR DOING THIS STUDY... 1 INTENDED AUDIENCE... 1 SCOPE OF REPORT... 2 METHODOLOGY... 2 INFORMATION SOURCES... 3 AUTHOR S CREDENTIALS...
More informationMolecular Diagnostics Market Share, Size, Analysis, Growth, Trends and Forecasts, 2016 to 2024 Hexa Research
Molecular Diagnostics Market Share, Size, Analysis, Growth, Trends and Forecasts, 2016 to 2024 Hexa Research " Projected to grow at a CAGR of almost 9% from 2016 to 2024, the molecular diagnostics market
More informationCountry Coverage. Company Coverage
Global Heart Valve Devices Market: Analysis By Procedure (Replacement & Repair), Replacement Procedure By Technique (Mechanical, Bioprosthetic & TAVR), Repair Procedure By Technique (Surgical, Balloon
More informationSAMPLE. Syringes and Needles Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to Reference Code: GDME0166BDB
Syringes and Needles Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 2018 Reference Code: GDME0166BDB Publication Date: January 2013 GlobalData. This report is a licensed product
More informationTODAY S VACCINATION ECOSYSTEM STATUS MARKET-SHAPING PRINCIPLES, PRACTICE, IMPACT AND LESSONS LEARNT GAVI PERSPECTIVE
TODAY S VACCINATION ECOSYSTEM STATUS MARKET-SHAPING PRINCIPLES, PRACTICE, IMPACT AND LESSONS LEARNT GAVI PERSPECTIVE Aurélia Nguyen Tuesday 20 January 2015, Veyrier-du-Lac, France www.gavi.org AGENDA Market
More informationTechnology Transfer from the Perspective of IFPMA vaccine members
Technology Transfer from the Perspective of IFPMA vaccine members WHO Workshop on Technology Transfer for Local Manufacturing Capacity of Vaccines Michael Watson (Sanofi Pasteur) Chair of IFPMA Biologicals
More informationThe Cigarette Market in Saudi Arabia
The Cigarette Market in Saudi Arabia Product Code: CG0173MR Published Date: June 2015 Report Price: US$ 975 (Single Copy) Synopsis Cigarettes in Saudi Arabia report is a qualitative report providing extensive
More informationEconomics of Vaccine Development A Vaccine Manufacturer s Perspective
Economics of Vaccine Development A Vaccine Manufacturer s Perspective Gerald Voss The Value of Vaccines 2 29 diseases are currently preventable by vaccination Global public health Cervical cancer 1 Diphtheria
More informationREFERENCE CODE GDHC1174DFR PUBLICATION DATE M AY 2013
REFERENCE CODE GDHC1174DFR PUBLICATION DATE M AY 2013 XELJANZ (PSORIASIS) - Executive Summary Table below presents key metrics for Xeljanz (tofacitinib) in seven of the nine major pharmaceutical markets
More informationTABLE 4 U.S. TEETH CLEANING VISITS BY SELECTED CHARACTERISTICS (%) TABLE 4 (CONTINUED) FIGURE 2 U.S. POPULATION WITH TEETH CLEANING
CHAPTER ONE: INTRODUCTION... 1 STUDY GOALS AND OBJECTIVES... 1 REASONS FOR DOING THE STUDY... 1 SCOPE OF REPORT... 1 METHODOLOGY... 2 ANALYST... 3 RELATED BCC STUDIES... 3 BCC ONLINE SERVICES... 3 DISCLAIMER...
More informationINCRETIN-BASED DRUGS: MARKETS FOR DIABETES THERAPIES AND DEVELOPING TREATMENTS
INCRETIN-BASED DRUGS: MARKETS FOR DIABETES THERAPIES AND DEVELOPING TREATMENTS PHM162A February 2015 Kim Lawson Project Analyst ISBN: 1-62296-047-5 BCC Research 49 Walnut Park, Building 2 Wellesley, MA
More informationTABLE OF CONTENTS. HLC102A - Continuous Glucose Monitoring (CGM): Technologies and Global Markets
TABLE OF CONTENTS CHAPTER 1 INTRODUCTION 1 STUDY GOALS AND OBJECTIVES 1 REASONS FOR DOING THIS STUDY 1 CONTRIBUTIONS TO THE STUDY AND INTENDED AUDIENCE 1 SCOPE AND FORMAT 1 METHODOLOGY AND INFORMATION
More informationBOTANICAL AND PLANT-DERIVED DRUGS: GLOBAL MARKETS
BOTANICAL AND PLANT-DERIVED DRUGS: GLOBAL MARKETS BIO022G August 2015 Kim Lawson Project Analyst ISBN: 1-62296-134-X BCC Research 49 Walnut Park, Building 2 Wellesley, MA 02481 USA 866-285-7215 (toll-free
More informationOligonucleotide Testing Market Analysis, Size, Share, Growth, Industry Trends and Forecast to 2024 Hexa Research
Oligonucleotide Testing Market Analysis, Size, Share, Growth, Industry Trends and Forecast to 2024 Hexa Research Oligonucleotide Testing Market is expected to witness a significant growth, pertaining to
More informationREFERENCE CODE GDHC317DFR PUBLICAT ION DATE DECEMBER 2013 LUCENTIS (MICROVASCULAR COMPLICATIONS OF DIABETES) - FORECAST AND MARKET ANALYSIS TO 2022
REFERENCE CODE GDHC317DFR PUBLICAT ION DATE DECEMBER 2013 LUCENTIS Executive Summary The table below presents a summary of the key metrics for Lucentis (Microvascular Complications for Diabetes) for recombinant
More informationOrgan Transplantation Market Research Report- Global Forecast Till 2023
Report Information More information from: https://www.marketresearchfuture.com/reports/915 Organ Transplantation Market Research Report- Global Forecast Till 2023 Report / Search Code: MRFR/HC/0410-HCRR
More informationTHERAPIES AND BIOMARKERS FOR INFLAMMATORY BOWEL DISEASE
THERAPIES AND BIOMARKERS FOR INFLAMMATORY BOWEL DISEASE PHM125A January 2013 Willem Westra Project Analyst ISBN: 0-89336-715-X BCC Research 49 Walnut Park, Building 2 Wellesley, MA 02481 866-285-7215,
More informationStainless-steel vs Single-use: The Vaccines Perspective
Stainless-steel vs Single-use: The Vaccines Perspective CMO-Biomanufacturer Panel Tue 21 April, Noon-1:30pm, Exhibit Hall Daniel C.Vellom, PhD Sr. Director Global Technology Innovation 2015 INTERPHEX 1
More informationEU5 Bariatric Surgery Procedures Outlook to 2020
EU5 Bariatric Surgery Procedures Outlook to 2020 Reference Code: GDMECR0089PDB Publication Date: July 2014 Page 1 1 Table of Contents 1 Table of Contents... 2 1.1 List of Tables... 3 1.2 List of Figures...
More informationGlobal Nutraceuticals Market
Published on NOVONOUS (https://www.novonous.com) Home > Global Nutraceuticals Market 2016-2020 Global Nutraceuticals Market 2016-2020 Publication ID: NOV1016004 Publication Date: October 14, 2016 Pages:
More informationCreating VaCCines, ProteCting Life
Creating VaCCines, ProteCting Life PreVenting Disease through VaCCination a Constant BattLe Immunization has been a great public health success story. The lives of millions of children have been saved,
More informationMexico Ostomy Drainage Bags Market Outlook to 2020
Mexico Ostomy Drainage Bags Market Outlook to 2020 Reference Code: GDMECC0990DB Publication Date: October 2014 Page 1 1 Table of Contents 1 Table of Contents... 2 1.1 List of Tables... 4 1.2 List of Figures...
More informationOperatory Units TABLE 20 SELECT MANUFACTURERS AND DISTRIBUTORS OF DENTAL FURNITURE TABLE 20 (CONTINUED) Cavity Preparation Systems
CHAPTER ONE: INTRODUCTION... 1 STUDY GOALS AND OBJECTIVES... 1 REASONS FOR DOING THE STUDY... 1 SCOPE AND FORMAT... 1 METHODOLOGY... 1 RELATED BCC STUDIES... 2 ANALYST CREDENTIALS... 2 BCC ON-LINE SERVICES...
More informationSAMPLE. Sterilization and Disinfectant Equipment Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 2018
Sterilization and Disinfectant Equipment Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 2018 Reference Code: GDME0165BDB Publication Date: January 2013 GlobalData. This report
More informationChina Cranio Maxillofacial Fixation (CMF) Market Outlook to 2020
China Cranio Maxillofacial Fixation (CMF) Market Outlook to 2020 Reference Code: GDMECC0079DB Publication Date: March 2014 Page 1 1 Table of Contents 1 Table of Contents... 2 1.1 List of Tables... 4 1.2
More informationWHO HHS Workshop on Business Modeling for Sustainable Influenza Vaccine Manufacturing
WHO HHS Workshop on Business Modeling for Sustainable Influenza Vaccine Manufacturing Washington, DC January 14th 16th, 2013 Session 4: Attracting Investments and Generating Revenue Theory, Practice and
More informationPoultry Diagnostics Market by Test (ELISA, PCR) Disease (Avian Salmonellosis, Avian Influenza, Newcastle Disease, Avian Pasteurellosis,
Poultry Diagnostics Market by Test (ELISA, PCR) Disease (Avian Salmonellosis, Avian Influenza, Newcastle Disease, Avian Pasteurellosis, Encephalomyelitis, Infectious Bronchitis), Service (Virology, Bacteriology,
More informationREFERENCE CODE GDHC294DFR PUBLICATION DATE NOVEMBER 2013 PROTOPIC (ATOPIC DERMATITIS) FORECAST AND MARKET ANALYSIS TO 2022
REFERENCE CODE GDHC294DFR PUBLICATION DATE NOVEMBER 2013 PROTOPIC (ATOPIC DERMATITIS) Executive Summary The below mentioned table presents key metrics for Protopic in the nine major pharmaceutical markets
More informationSleep apnea devices Market Research Report- Global Forecast To 2022
Report Information More information from: https://www.marketresearchfuture.com/reports/2061 Sleep apnea devices Market Research Report- Global Forecast To 2022 Report / Search Code: MRFR/HC/1529-HCRR Publish
More informationPrevention and Treatment of Prostate Cancer: Technologies and Global Markets March Usha Nagavarapu. Report # PHM113B
Prevention and Treatment of Prostate Cancer: Technologies and Global Markets March 2017 Usha Nagavarapu Report # PHM113B Table of Contents Chapter 1 Introduction... 1 Introduction... 1 Study goals and
More informationThe protective power of vaccination
The protective power of vaccination Life is a health journey; help protect it against life-threatening infectious diseases. Smallpox used to kill millions of people worldwide¹. Polio paralyzed and killed
More informationAsia-Pacific Endoscopic Retrograde Cholangiopancreatography (ERCP) Procedures Outlook to 2020
Asia-Pacific Endoscopic Retrograde Cholangiopancreatography (ERCP) Reference Code: GDMECR0107PDB Publication Date: July 2014 Page 1 1 Table of Contents 1 Table of Contents... 2 1.1 List of Tables... 3
More informationGlobal Chemotherapy Induced Nausea & Vomiting (CINV) Market: Size, Trends & Forecasts ( ) September 2016
Global Chemotherapy Induced Nausea & Vomiting (CINV) Market: Size, Trends & Forecasts (2016-2020) September 2016 Global CINV Market Report Scope of the Report The report titled Global Chemotherapy Induced
More informationTAKEDA VACCINES INNOVATION FOR GLOBAL IMPACT. RAJEEV VENKAYYA, MD President, Global Vaccine Business Unit
TAKEDA VACCINES INNOVATION FOR GLOBAL IMPACT RAJEEV VENKAYYA, MD President, Global Vaccine Business Unit OUR MISSION Develop and deliver innovative vaccines that tackle the toughest problems in public
More informationMedical Morphine Market Size, Share, Growth, Analysis, Trends, and Forescast to 2024 Hexa Research
Medical Morphine Market Size, Share, Growth, Analysis, Trends, and Forescast to 2024 Hexa Research Increasing use of the drug to relieve pain in cancer, arthritis and postoperative surgeries is expected
More informationThe Cigarette Market in Greece
The Cigarette Market in Greece Product Code: CG0145MR Published Date: April 2015 Report Price: US$ 975 (Single Copy) Synopsis Cigarettes in Greece report is a qualitative report providing extensive and
More informationVACCINATION. DR.FATIMA ALKHALEDY M.B.Ch.B;F.I.C.M.S/C.M.
VACCINATION DR.FATIMA ALKHALEDY M.B.Ch.B;F.I.C.M.S/C.M. IMMUNIZATION Immunization is defined as the procedure by which the body is prepared to fight against a specific disease. It is used to induce the
More informationSAMPLE. Asia-Pacific Drug Delivery Devices Market Outlook to Metered Dose Inhaler Devices, Infusion Systems, Central Venous
Asia-Pacific Drug Delivery Devices Market Outlook to 2018 - Metered Dose Inhaler Devices, Infusion Systems, Central Venous Catheters and Others Reference Code: GDME0220RDB Publication Date: January 2013
More informationCHAPTER THREE: INDUSTRY OVERVIEW... 6 HISTORICAL PERSPECTIVE OF THE MENTAL HEALTH INDUSTRY... 6 HISTORICAL PERSPECTIVE OF THE (CONTINUED)...
CHAPTER ONE: INTRODUCTION... 1 STUDY GOALS AND OBJECTIVES... 1 REASONS FOR STUDY... 1 SCOPE OF STUDY... 1 METHODOLOGY AND INFORMATION SOURCES... 2 ANALYST CREDENTIALS... 2 RELATED BCC REPORTS... 2 DISCLAIMER...
More informationREFERENCE CODE GDHC282DFR PUBLICATION DATE OCTOBER 2013 BELVIQ (OBESITY) - FORECAST AND MARKET ANALYSIS TO 2022
REFERENCE CODE GDHC282DFR PUBLICATION DATE OCTOBER 2013 BELVIQ (OBESITY) - Executive Summary Below table provides a summary of Belviq for obesity in the nine major pharmaceutical markets during the forecast
More informationVACCINE PRODUCTION IN DEVELOPING COUNTRIES: AN ECONOMIC EVALUATION
VACCINE PRODUCTION IN DEVELOPING COUNTRIES: AN ECONOMIC EVALUATION Syarifah Liza Munira, PhD Department of Economics, Faculty of Economics and Business, Universitas Indonesia liza.munira@ui.ac.id; lizamunira@yahoo.com
More informationAcquisition of Novartis Influenza Vaccines Business. 27 th October 2014
1 Acquisition of Novartis Influenza Vaccines Business 27 th October 2014 2 Legal Notice Forward looking statements The materials in this presentation speak only as of the date of these materials, and include
More information